Austin Top 50
Author:
BIOMARIN PHARMACEUTICAL INC.
BioMarin Reports First Quarter 2026 Financial and Operating Results
May 5, 2026
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society’s 2026 Annual Meeting
May 4, 2026
Blue-Collar Blessed by Denny LaVé Recognized as No. 1 International Bestseller Across the United States, Canada, and Australia
April 25, 2026
Denny LaVé Announces Launch of Blue-Collar Blessed, a Memoir of Faith, Leadership, and Hard-Won Resilience
March 26, 2026
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
March 12, 2026